ONCOLOGY: Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma
Feb 29, 2008 - 00:06:12
Radio and PodcastLive Radio & PodcastsScience & Medicine
ONCOLOGY: Dasatinib Effective At Two Years’ Follow Up in Chronic Phase CML
Audio Journal of Oncology, December 9th, 2007 Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta Dasatinib Effective At Two Years’ Follow Up in Chronic Phase CML RICHARD STONE, Dan...
Related Episodes
Continue listening to more episodes from Audio Medica News - Medical News Interviews.
ONCOLOGY: "Total Therapy" Possible Cure For Multiple Myeloma?
Feb 29, 2008 - 00:05:16
ONCOLOGY: Multiple Myeloma: Towards A Chronic Disease With Cure On The Horizon
Feb 27, 2008 - 00:10:52
MEDICINE: Meta-Analysis Proves Statins Help Patients With Diabetes
Jan 11, 2008 - 00:04:52
ONCOLOGY: New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer
Dec 15, 2007 - 00:03:02
ONCOLOGY: ATAC Trial: Anastrozole Still Superior At Over Eight Years’ Follow Up
Dec 15, 2007 - 00:06:36
ONCOLOGY: Early Breast Cancer: Survival Benefit For Adjuvant Docetaxel/Cyclophosphamide
Dec 14, 2007 - 00:05:02